WVE-N531 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-06-27 in 5d
ESTIMATED |
READOUT
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWA
Phase 1/2 · Duchenne Muscular Dystrophy |
WVE Wave Life Sciences Ltd. | WVE-N531 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|